TB4 Frag 17–23 – Synthetic Peptide Fragment (500 mcg Capsules)

Product Overview

TB4 Frag 17–23 is a synthetic peptide fragment derived from the Thymosin Beta-4 (TB500) sequence, spanning amino acid residues 17 to 23. Supplied in capsule form, this compound is intended exclusively for in vitro and non-human laboratory models where cellular migration, actin-binding dynamics, or peptide-based signaling pathways are under investigation.

Formulated and encapsulated under cGMP laboratory protocols in the USA, this product is not intended for human or veterinary use, and no therapeutic or diagnostic claims are made.

Key Product Details

Research Applications

TB4 Frag 17–23 is used in laboratory settings for:

• Cell Migration Models: Studies evaluating cellular motility, actin polymerization, and matrix interactions
• Cytoskeletal Research: Exploration of peptide influence on intracellular actin-binding proteins
• Wound Healing & Tissue Studies: In vitro assays investigating structural cell response and regeneration modeling
• Signal Transduction Assays: Preclinical peptide–protein interaction analysis and pathway mapping

This product is for investigational use only and is not intended for in vivo or clinical experimentation.

Storage & Handling

• Store at room temperature in a low-humidity, sealed container
• Avoid prolonged exposure to heat, light, or moisture
• Only open and handle in certified lab environments
• Follow all institutional safety protocols for synthetic peptide research

Regulatory & Compliance Statement

• This compound is not a drug, supplement, or medical product
• It is not intended to diagnose, treat, prevent, or cure any condition
• Any use outside of lawful laboratory research voids all warranties and compliance status

Disclaimer

TB4 Frag 17–23 is supplied exclusively for scientific research and analytical purposes by trained professionals in approved laboratory facilities. Any off-label or unauthorized application is strictly prohibited and may violate federal regulations.